View in EDS

MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.

Saved in:
Bibliographic Details
Title: MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.
Authors: Zhang P; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Bill K, Liu J, Young E, Peng T, Bolshakov S, Hoffman A, Song Y, Demicco EG, Terrada DL, Creighton CJ, Anderson ML, Lazar AJ, Calin GG, Pollock RE, Lev D
Source: Cancer research [Cancer Res] 2012 Apr 01; Vol. 72 (7), pp. 1751-62. Date of Electronic Publication: 2012 Feb 20.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 22350414
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhang+P%22">Zhang P</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.<br /><searchLink fieldCode="AU" term="%22Bill+K%22">Bill K</searchLink><br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink><br /><searchLink fieldCode="AU" term="%22Young+E%22">Young E</searchLink><br /><searchLink fieldCode="AU" term="%22Peng+T%22">Peng T</searchLink><br /><searchLink fieldCode="AU" term="%22Bolshakov+S%22">Bolshakov S</searchLink><br /><searchLink fieldCode="AU" term="%22Hoffman+A%22">Hoffman A</searchLink><br /><searchLink fieldCode="AU" term="%22Song+Y%22">Song Y</searchLink><br /><searchLink fieldCode="AU" term="%22Demicco+EG%22">Demicco EG</searchLink><br /><searchLink fieldCode="AU" term="%22Terrada+DL%22">Terrada DL</searchLink><br /><searchLink fieldCode="AU" term="%22Creighton+CJ%22">Creighton CJ</searchLink><br /><searchLink fieldCode="AU" term="%22Anderson+ML%22">Anderson ML</searchLink><br /><searchLink fieldCode="AU" term="%22Lazar+AJ%22">Lazar AJ</searchLink><br /><searchLink fieldCode="AU" term="%22Calin+GG%22">Calin GG</searchLink><br /><searchLink fieldCode="AU" term="%22Pollock+RE%22">Pollock RE</searchLink><br /><searchLink fieldCode="AU" term="%22Lev+D%22">Lev D</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222984705R%22">Cancer research</searchLink> [Cancer Res] 2012 Apr 01; Vol. 72 (7), pp. 1751-62. <i>Date of Electronic Publication: </i>2012 Feb 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2984705R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-7445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200085472%22">00085472 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22350414
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/0008-5472.CAN-11-3027
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1751
    Titles:
      – TitleFull: MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhang P
      – PersonEntity:
          Name:
            NameFull: Bill K
      – PersonEntity:
          Name:
            NameFull: Liu J
      – PersonEntity:
          Name:
            NameFull: Young E
      – PersonEntity:
          Name:
            NameFull: Peng T
      – PersonEntity:
          Name:
            NameFull: Bolshakov S
      – PersonEntity:
          Name:
            NameFull: Hoffman A
      – PersonEntity:
          Name:
            NameFull: Song Y
      – PersonEntity:
          Name:
            NameFull: Demicco EG
      – PersonEntity:
          Name:
            NameFull: Terrada DL
      – PersonEntity:
          Name:
            NameFull: Creighton CJ
      – PersonEntity:
          Name:
            NameFull: Anderson ML
      – PersonEntity:
          Name:
            NameFull: Lazar AJ
      – PersonEntity:
          Name:
            NameFull: Calin GG
      – PersonEntity:
          Name:
            NameFull: Pollock RE
      – PersonEntity:
          Name:
            NameFull: Lev D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2012 Apr 01
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-electronic
              Value: 1538-7445
          Numbering:
            – Type: volume
              Value: 72
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Cancer research
              Type: main
ResultId 1